Australian Research. Global Outcomes.
ADDRI is an independent, not-for-profit research institute committed to reducing and ultimately eliminating the impact of asbestos and dust-related diseases worldwide.
What we do
We work in collaboration with individuals and organisations dedicated to eradicating asbestos and dust-related diseases while providing personalised and wrap-around support to those affected by them.
Learn moreResearch
Our evidence-led research drives advancements in medical and scientific understanding and guides our global education and training initiatives.
Our workFeatured Researcher
A/Professor Anthony Linton
Dr Linton is a senior staff specialist in medical oncology at the Concord Cancer Centre in Concord Repatriation General Hospital, specialising in thoracic, genitourinary and brain malignancies. Dr Linton received his medical degree at the University of New South Wales before completing physician and oncology training at Concord Repatriation General Hospital.
He has been associated with the Asbestos and Dust Diseases Research Institute since 2011, when he joined as the first Biaggio Signorelli Fellow and completed his PhD at ADDRI investigating prognostic factors and new therapeutic targets in malignant pleural mesothelioma. He continued to collaborate with ADDRI researchers in translational research projects as an expert advisor and in 2024 was appointed the academic and research director of the institute.
He has published widely in international peer reviewed journals and he has presented on mesothelioma and other thoracic malignancies at national and international meetings. Dr Linton is a principal investigator on a number of clinical trials and is passionate regarding the translation of research from the laboratory to the clinic.
Dr Linton has a keen interest in education and training, previously serving as network director of physician training at the Concord Hospital Network, and is a senior clinical lecturer at the University of Sydney.
Research quicklinks
Education
We are on a mission to educate that asbestos is a very real threat to people all over the world.
eToolkit
Bringing together over 60 specific topics and written in collaboration with 100 global
experts, this online education resource provides a comprehensive guide in how to diagnose
and treat asbestos-related diseases.
Learning Modules
Nurses and allied health professionals can access our Specialist Mesothelioma eLearning
resource. This comprehensive one-stop resource is designed as a 30-minute module,
following a chronological timeline in a patient’s mesothelioma journey.
Podcast
Listening to people’s stories is very powerful. If you have been diagnosed – or are caring for
someone who has – we have a series of inspiring conversations to offer information,
understanding and hope.
Support
Have you been impacted?
We have a dedicated and compassionate team of specialist registered nurses who can provide you with the most current clinical information, referral pathways and emotional support via phone and email as well as a number of peer support groups. We're here to help you.
Stories
Trevor's Story
When Trevor and his wife Shirley returned home to Australia after being overseas feeling increasingly breathless, Trevor received a call that would change his life forever.
Read moreResearch Projects
Working towards early diagnosis
This project aims to identify and validate new blood-based biomarkers to facilitate an improved and less invasive diagnosis of mesothelioma.
Read moreSTORIES
Raul's story
Raúl Antonio Medina Ortiz worked as a Logistics Assistant for over 14 years for Incolbest SA, a company in Colombia manufacturing parts for vehicle brakes.
Read moreSTORIES
An Indonesian Story
Tuniah and Kuswoyo worked for the Trigraha Sealsindo company, an asbestos manufacturer for automotive parts in Indonesia for over 20 years.
Read moreLatest news
All news
Our supporters
Our ability to advance our research is only made possible through the generosity of our supporters and collaboration with organisations and individuals dedicated to eradicating asbestos and dust related diseases.
Learn more
